Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking

K. V. Doboch (St-Petersburg, Russia)

Source: Annual Congress 2002 - COPD - Drug therapy 2
Session: COPD - Drug therapy 2
Session type: Thematic Poster Session
Number: 1591
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. V. Doboch (St-Petersburg, Russia). Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking. Eur Respir J 2002; 20: Suppl. 38, 1591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004

Evaluation of airway sGaw in Japanese COPD patients treated with triple therapy using salmeterol/fluticasone propionate 50/250 and tiotropium bromide
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Pulmonary function and bronchodilator response to albuterol, ipratropium bromide and association of albuterol and ipratropium bromide in children with cystic fibrosis (CF)
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

Sleep architecture in COPD patients during salmeterol versus tiotropium bromide treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 199s
Year: 2006

Cardiopulmonary effects of inhaled ipratropium bromide and its combination with fenoterol in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002

A comparison of early bronchodilating responses of Salbutamol, Ipratropium bromide, and the combination of Ipratropium bromide-Salbutamol in stable patients with COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 356s
Year: 2007

Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004

Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002

Acute effect of formoterol, salmeterol, albuterol, oxitropium bromide and placebo on FEV1, inspiratory capacity and dyspnoea in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 380s
Year: 2001

Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Comparative study of one-year treatment with salmeterol along, and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructi e pulmonary diseases (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003

Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Evaluation of IL-8 and MEF25-75 in patients with severe COPD who were treated with combined therapy of ICSs / LABAs plus tiotropium bromide
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

The influence of tiotropium bromide on neutrophiles function of bronchial region in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010

The combination therapy with inhaled tiotropium bromide and transdermal tulobuterol in COPD improves the peripheral airway function
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

A comparison of bronchodilating response of salbutamol, ipratropium bromide and the combination of ipratropium-salbutamol in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001

Influence of tiotropium bromide on quantity of exacerbations and survival rate of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 74s
Year: 2007